• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Molecular Diagnostics Market by Application, Technology, End User, Product - Global Forecasts to 2018 - Product Image

Molecular Diagnostics Market by Application, Technology, End User, Product - Global Forecasts to 2018

  • ID: 2298239
  • October 2012
  • Region: Global
  • 392 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Abbott Diagnostics
  • Biocartis
  • Cepheid
  • Genmark Diagnostics
  • Innogenetics Nv
  • Luminex Corporation
  • MORE

Molecular diagnostics (MDx) is a new class of diagnostic tests that identify nucleic acids or proteins to test the status of a disease. These nucleic acids or proteins, which belong to individual patients or foreign organisms, help determine a specific therapy, or risk of developing a specific disease, or other health conditions. MDx is the fastest growing segment within the in-vitro diagnostic (IVD) space, driven by accuracy, high sensitivity, fast turnaround time, easy workflow, and cost-effective testing. Owing to these factors, the molecular diagnostics market crossed $4.8 billion in 2011, and is poised to grow at a CAGR of 9.1% in the next five years.

MDx involves instruments and reagents that leverage multiple technologies to identify genetic variations. The technologies utilized in molecular diagnostics include polymerase chain reaction (PCR), transcription mediated amplification (TMA), hybridization (In-situ Hybridization & fluorescence in situ hybridization (FISH)), DNA Sequencing, next generation sequencing (NGS), microarrays, and others.

Molecular diagnostics (MDx) has emerged as one of the largest and fastest growing segments in the In vitro Diagnostic READ MORE >

FEATURED COMPANIES

  • Abbott Diagnostics
  • Biocartis
  • Cepheid
  • Genmark Diagnostics
  • Innogenetics Nv
  • Luminex Corporation
  • MORE

1 Introduction

1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation & Data Triangulation
1.6.2 Key Data From Secondary Sources
1.6.3 Key Data Points From Primary Sources
1.6.4 Assumptions

2 Executive Summary

3 Premium Insight

4 Market Overview

4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3.1.2 Development of Biomarker Identification and Advancements in Molecular Techniques
4.3.1.3 Proteomics and Genomics Technology Research to Goad the Molecular Testing Market
4.3.1.4 Increase in AGing Population to Spur Growth of the Molecular Diagnostics Market
4.3.1.5 Reformations in the Reimbursement System
4.3.2 Restraints
4.3.2.1 Increased Costs of Molecular Diagnostics tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
4.3.2.2 Reimbursement Issues
4.3.2.3 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
4.3.3 Opportunities
4.3.3.1 Extending the Reach of Molecular Diagnostics
4.3.3.2 Emerging Technologies Can Soon Gain Importance in Molecular Diagnostic Tests
4.3.4 Threats
4.3.4.1 Lack of Budget and Labor
4.3.4.2 Stringent Regulatory Framework to Stifle the Growth of Mdx Market
4.4 Market Share Analysis
4.5 Molecular Diagnostic Laboratories and Tests
4.6 End-User Analysis
4.7 Effects of Obamacare on the Molecular Diagnostics Market

5 Global Molecular Diagnostics Market, By Application

5.1 Introduction
5.2 Infectious Diseases
5.2.1 Hepatitis B Virus (HBV)
5.2.2 Hepatitis C Virus (HCV)
5.2.3 Human Immunodeficiency Virus (HIV)
5.2.4 Tuberculosis (TB)
5.2.5 Chlamydia Trachomatis and Neisseria Gonorrhea (CT/NG)
5.2.6 Human Papillomavirus (HPV)
5.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.8 Others
5.3 oncology
5.3.1 Prostate Cancer
5.3.2 Breast Cancer
5.3.3 Colorectal Cancer
5.3.4 Others
5.4 Genetics
5.5 Blood Screening
5.6 Microbiology
5.7 Others

6 Global Molecular Diagnostics Market, By Technology

6.1 Introduction
6.2 Polymerase Chain Reaction (PCR)
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4 Microarrays
6.5 Hybridization (in Situ Hybridization and Fluorescence in Situ Hybridization)
6.6 Dna Sequencing & Next-Generation Sequencing
6.7 Others

7 Global Molecular Diagnostics Market, By Product Type

7.1 Introduction
7.2 Instruments
7.3 Reagents
7.4 Services & Software

8 Geographic Analysis

8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 U.K.
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia
8.4.1 Japan
8.4.2 India
8.4.3 China
8.4.4 Rest of Asia (ROA)
8.5 Rest of the World (ROW)
8.5.1 Latin America
8.5.2 Pacific
8.5.3 Middle East & Africa

9 Competitive Landscape

9.1 Introduction
9.2 New Product Launch
9.3 Mergers & Acquisitions
9.4 Agreement/Partnership/Collaboration
9.5 Expansion
9.6 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

10.1 Abbott Diagnostics, Inc.
10.2 Beckman Coulter, Inc.
10.3 Becton, Dickinson & Co.
10.4 Biomérieux Business Overview
10.5 Cepheid, Inc.
10.6 Gen-Probe, Inc. (Hologic, Inc.)
10.7 Novartis AG
10.8 Qiagen
10.9 Roche Diagnostics
10.1 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

- Abbott Diagnostics

- Beckman Coulter, Inc.

- Becton, Dickinson & Company

- Biocartis

- Biomerieux

- Cepheid

- Eurogentec Sa

- Genmark Diagnostics

- Genomic Health, Inc.

- Gen-Probe, Inc. (Hologic, Inc.)

- Innogenetics Nv

- Intelligentmdx

- Life Technologies Corporation

- Luminex Corporation

- Myriad Genetics, Inc.

- Novartis Ag

- Qiagen

- Roche Diagnostics

- Seegene

- Siemens Healthcare

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos